𝔖 Bobbio Scriptorium
✦   LIBER   ✦

W1279 Mucosal Healing With Methotrexate in Crohn's Disease: A Prospective Comparative Study With Azathioprine and Infliximab

✍ Scribed by Laharie, David; Reffet, Armel; Chabrun, Edouard; Subtil, Clement; Razaire, Sylvie; de Ledinghen, Victor

Book ID
121999816
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
67 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined approach with infliximab, surge
Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study
✍ Pauline RoumeguΓ¨re; Dominique Bouchard; FranΓ§ois Pigot; Alain Castinel; Frederic πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 310 KB

Background: Infliximab is the only medical therapy that has been proven to be effective in fistulizing Crohn's disease (CD), but the recurrence rate of fistulas is high despite maintenance therapy. The aim of this prospective study was to evaluate the short-and long-term efficacy of a combined sched

Mucosal healing predicts long-term outco
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease
✍ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 395 KB πŸ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients